It is also worth noting that stronger inhibition of hepcidin-25 and significantly greater improvement in RA-anemia were observed in patients treated with tocilizumab than in patients treated with TNF-α inhibitors throughout the observation period. This evidence concerns the gene TNF and rheumatoid arthritis.